AVBP compared with LEGN: revenue, margins and what each company keeps, and the suppliers and customers both name

AVBPArriVent BioPharma, Inc.

Mkt capRevenueRevenue

LEGNLegend Biotech Corp

Mkt capRevenueRevenue

Compare

AVBPArriVent BioPharma, Inc.

LEGNLegend Biotech Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

AVBP: latest quarter not drawable. LEGN: latest quarter not drawable.Method ›

Price

rebased to 0%

AVBP, solidLEGN, dashed

AVBPArriVent BioPharma, Inc.

14.93▼−6.41%· post 14.72

Mkt cap$707.9M

LEGNLegend Biotech Corp

21.63▼−3.03%· post 21.63

ClosedOct 30 '26

Mkt cap$4.0B

Compare

ClosedOct 30 '26

AVBPArriVent BioPharma, Inc.

LEGNLegend Biotech Corp

14.93▼−6.41%post 14.72

Price

21.63▼−3.03%post 21.63

$707.9M

Mkt cap

$4.0B

AVBP14.93▼−6.41%vsLEGN21.63▼−3.03%ClosedOct 30 '26

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AVBP 8

—Shanghai Allist Pharmaceuticalsunlistedsupplier

—Lepu Biopharmaunlistedsupplier

—Aarvik Therapeuticsunlistedsupplier

—Jiangsu Alphamab Biopharmaceuticalsunlistedsupplier

4 more · AVBP chain ›

Shared 0

No shared counterparties.

Only LEGN 1

JNJJanssencustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR